Literature DB >> 27186515

Rebuttal from Prof. Kong and Dr. Rabatic.

Bryan M Rabatic1, Feng-Ming Spring Kong1.   

Abstract

Year:  2016        PMID： 27186515      PMCID： PMC4858574          DOI： 10.21037/tlcr.2016.04.02

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  15 in total

1.  Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study.

Authors:  Pierre Fournel; Gilles Robinet; Pascal Thomas; Pierre-Jean Souquet; Hervé Léna; Alain Vergnenégre; Jean-Yves Delhoume; Jacques Le Treut; Jules-Antoine Silvani; Eric Dansin; Marie-Cécile Bozonnat; Jean-Pierre Daurés; Françoise Mornex; Maurice Pérol
Journal:  J Clin Oncol       Date:  2005-08-08       Impact factor: 44.544

2.  Non-Small Cell Lung Cancer, Version 6.2015.

Authors:  David S Ettinger; Douglas E Wood; Wallace Akerley; Lyudmila A Bazhenova; Hossein Borghaei; David Ross Camidge; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Thomas J Dilling; M Chris Dobelbower; Ramaswamy Govindan; Frederic W Grannis; Leora Horn; Thierry M Jahan; Ritsuko Komaki; Lee M Krug; Rudy P Lackner; Michael Lanuti; Rogerio Lilenbaum; Jules Lin; Billy W Loo; Renato Martins; Gregory A Otterson; Jyoti D Patel; Katherine M Pisters; Karen Reckamp; Gregory J Riely; Eric Rohren; Steven E Schild; Theresa A Shapiro; Scott J Swanson; Kurt Tauer; Stephen C Yang; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2015-05       Impact factor: 11.908

3.  Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.

Authors:  K Furuse; M Fukuoka; M Kawahara; H Nishikawa; Y Takada; S Kudoh; N Katagami; Y Ariyoshi
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

4.  Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Authors:  Walter J Curran; Rebecca Paulus; Corey J Langer; Ritsuko Komaki; Jin S Lee; Stephen Hauser; Benjamin Movsas; Todd Wasserman; Seth A Rosenthal; Elizabeth Gore; Mitchell Machtay; William Sause; James D Cox
Journal:  J Natl Cancer Inst       Date:  2011-09-08       Impact factor: 13.506

5.  Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

Authors:  George Rodrigues; Hak Choy; Jeffrey Bradley; Kenneth E Rosenzweig; Jeffrey Bogart; Walter J Curran; Elizabeth Gore; Corey Langer; Alexander V Louie; Stephen Lutz; Mitchell Machtay; Varun Puri; Maria Werner-Wasik; Gregory M M Videtic
Journal:  Pract Radiat Oncol       Date:  2015 May-Jun

6.  Imaging during radiation therapy captures abrupt and dramatic changes.

Authors:  Feng-Ming Spring Kong; Ka Kit Wong; Timothy Ritter
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

7.  Changes in functional lung regions during the course of radiation therapy and their potential impact on lung dosimetry for non-small cell lung cancer.

Authors:  Xue Meng; Kirk Frey; Martha Matuszak; Stanton Paul; Randall Ten Haken; Jinming Yu; Feng-Ming Spring Kong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-01       Impact factor: 7.038

8.  Non-cancer-related mortality after cisplatin-based adjuvant chemotherapy for non-small cell lung cancer: a study-level meta-analysis of 16 randomized trials.

Authors:  Fausto Petrelli; Sandro Barni
Journal:  Med Oncol       Date:  2013-06-28       Impact factor: 3.064

9.  Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study.

Authors:  Petr Zatloukal; Lubos Petruzelka; Milada Zemanova; Libor Havel; Filip Janku; Libor Judas; Antonin Kubik; Evzen Krepela; Pavel Fiala; Ladislav Pecen
Journal:  Lung Cancer       Date:  2004-10       Impact factor: 5.705

10.  Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.

Authors:  Mary Feng; Feng-Ming Kong; Milton Gross; Shaneli Fernando; James A Hayman; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.